封面
市场调查报告书
商品编码
1741202

血浆扩张剂市场按产品类型、应用、最终用户和地区划分

Plasma Expander Market, By Type, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

血浆扩张器市场规模预计在 2025 年为 88.1 亿美元,预计到 2032 年将达到 200.9 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 12.5%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 88.1亿美元
效能数据 2020-2024 预测期 2025-2032
预测期间:2025年至2032年的复合年增长率 12.50% 2032年价值预测 200.9亿美元

过去几年,全球血浆扩容剂市场显着成长。血浆扩容剂是手术和创伤期间使用的血液容量替代液,用于增加血管内容量和有效循环血量。当无法输注血液製品时,血浆扩容剂可透过紧急增加血浆来预防或治疗低血容性休克。常见的血浆扩容剂包括白蛋白、聚葡萄糖、羟乙基淀粉和明胶。该市场的成长归因于外科手术、创伤和事故的增加、老龄人口的增长以及慢性病数量的增加。然而,血浆扩容剂的副作用和高昂的治疗费用等因素可能会阻碍市场的成长。

市场动态

全球血浆扩容剂市场主要受创伤、烧烫伤和外科手术日益增长的推动。根据世界卫生组织 (WHO) 的数据,全球每年有超过 450 万人遭受致命伤害。道路交通事故、暴力、战争和其他原因导致了创伤的增加。此外,根据美国烧伤协会的数据,每年有超过 45 万名烧伤患者在美国专门的烧伤中心接受治疗。血浆扩容剂对于治疗这种情况下出血性休克至关重要。然而,合成胶体成本高以及过度使用和长期使用引起的副作用等因素正在抑制市场成长。同时,对新型血浆扩容剂配方的持续研究将为预测期间的市场扩张提供机会。

研究的主要特点

  • 本报告对全球血浆扩张器市场进行了详细分析,并提供了预测期(2025-2032)的市场规模和年复合成长率(CAGR%),假设 2024 年为基准年。
  • 它还揭示了各个领域的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、业绩和策略等参数,介绍了全球血浆扩张器市场的主要企业概况。
  • 本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球血浆扩张器市场报告针对该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过全球血浆扩张器市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 全球慢性病盛行率不断上升
    • 监管挑战
    • 新兴市场
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 合併、收购和合作

4. 全球血浆扩张剂市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球血浆扩张剂市场(按类型),2020-2032

  • 介绍
  • 白蛋白
  • 聚葡萄糖
  • 羟乙基淀粉
  • 明胶
  • 其他的

6. 全球血浆扩张剂市场(依产品类型),2020 年至 2032 年

  • 介绍
  • 胶体
  • 合成膨鬆剂

7. 全球血浆扩张剂市场(按应用)2020-2032

  • 介绍
  • 创伤与手术
  • 烧烫伤管理
  • 低血容量
  • 运动医学
  • 其他的

8. 全球血浆扩张剂市场(依最终用户划分),2020 年至 2032 年

  • 介绍
  • 医院和诊所
  • 门诊手术中心
  • 其他的

9. 全球血浆扩张剂市场(按地区划分),2020-2032 年

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 东南亚国协
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 中东和非洲
    • 海湾合作委员会国家
    • 以色列
    • 南非
    • 北非
    • 中部非洲
    • 其他中东地区

第十章 竞争格局

  • 公司简介
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • CSL Limited
    • Grifols, SA
    • B. Braun Melsungen AG
    • Hikma Pharmaceuticals PLC
    • Octapharma AG
    • Terumo Corporation
    • JW Life Science
    • Haemonetics Corporation
    • Macopharma
    • ADMA Biologics
    • BIoTest AG
    • Takeda Pharmaceutical Company Limited

第 11 章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5939

Plasma Expander Market is estimated to be valued at USD 8.81 Bn in 2025 and is expected to reach USD 20.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.81 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.50% 2032 Value Projection: USD 20.09 Bn

The global plasma expanders market is witnessing a significant growth over the past few years. Plasma expanders are blood volume replacement fluids used during surgery or trauma to increase intravascular volume of circulating blood and effective circulating volume. They prevent or treat hypovolemic shock by expanding blood plasma on an emergency basis in case when transfusion of blood products is not feasible. Some common plasma expanders include albumin, dextran, hydroxyethyl starch, and gelatin. Growth of this market can be attributed to growing number of surgical procedures, trauma and accident cases, rising geriatric population, and increase in chronic diseases. However, factors such as side effects associated with plasma expanders and high costs of treatment may hamper the market growth.

Market Dynamics

Global plasma expander market is primarily driven by the growing prevalence of trauma, burns, and surgical procedures that often involve significant blood loss. According to the World Health Organization (WHO), over 4.5 MN people suffer fatal injuries annually worldwide. Road accidents, violence, wars, and other such causes have contributed to rising trauma cases. Moreover, according to the American Burn Association, over 450,000 burn injuries are treated in specialized American burn centers each year. Plasma expanders form an integral part of the management of hemorrhagic shock in such conditions. However, factors such as the high costs of synthetic colloids and side effects with excessive or prolonged use restrain the market growth. On the other hand, ongoing research on new plasma expander formulations presents an opportunity for market expansion over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global plasma expander market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global plasma expander market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Baxter International Inc., Fresenius SE & Co. KGaA, CSL Limited, Grifols, S.A., B. Braun Melsungen AG, Hikma Pharmaceuticals PLC, Octapharma AG, Terumo Corporation, JW Life Science, Haemonetics Corporation, Macopharma, ADMA Biologics, Biotest AG, and Takeda Pharmaceutical Company Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global plasma expander market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasma expander market

Detailed Segmentation:

  • Global Plasma Expander Market, By Type:
    • Albumin
    • Dextran
    • Hydroxyethyl Starch
    • Gelatin
    • Others
  • Global Plasma Expander Market, By Product Type:
    • Colloids
    • Crystalloids
  • Global Plasma Expander Market, By Application:
    • Trauma and Surgical Procedures
    • Burn Management
    • Hypovolemia
    • Sports Medicine
    • Others
  • Global Plasma Expander Market, By End User:
    • Hospitals and Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Plasma Expander Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • CSL Limited
    • Grifols, S.A.
    • Braun Melsungen AG
    • Hikma Pharmaceuticals PLC
    • Octapharma AG
    • Terumo Corporation
    • JW Life Science
    • Haemonetics Corporation
    • Macopharma
    • ADMA Biologics
    • Biotest AG
    • Takeda Pharmaceutical Company Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising prevalence of chronic diseases across the world
    • Regulatory challenges
    • Emerging markets
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Plasma Expander Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Plasma Expander Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Albumin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Dextran
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Hydroxyethyl Starch
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Gelatin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Plasma Expander Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Colloids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Synthetic Expanders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Plasma Expander Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Trauma and Surgical Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Burn Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Hypovolemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Sports Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Plasma Expander Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Plasma Expander Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Sub-region2023 and 2032 (%)
    • Y-o-Y Growth Analysis, For Sub-regions, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User2018-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/ Sub-region, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • South Africa
      • North Africa
      • Central Africa
      • Rest of Middle East

10. Competitive Landscape

  • Company Profile
    • Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Fresenius SE & Co. KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • CSL Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Grifols, S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • B. Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Hikma Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Octapharma AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • JW Life Science
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Haemonetics Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Macopharma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • ADMA Biologics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Biotest AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Takeda Pharmaceutical Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst's Views

11. Section

  • References
  • Research Methodology
  • About us